{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52027886",
    "licUnit": "1",
    "validDate": "2025-05-19 00:00:00.000",
    "issueDate": "2020-05-19 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202788600",
    "prodNameC": "德露斯微脂體注射劑2毫克\/毫升",
    "prodNameE": "DOXLOX",
    "indicationsName": [
        "用於治療CD4數量低下(<200 D4 LYMPHOCYTES\/ MM3)和黏膜、皮膚或內臟有病變的AIDS RELATED KAPOSI’S SARCOMA的病人。用於治療曾接受第一線含鉑類藥物(PLATINUM-BASED)化學治療而失敗者或再復發之進行性或轉移性卵巢癌病人。可用於單一治療有心臟疾病風險考量之轉移性乳癌患者。可與bortezomib併用治療於曾接受過至少一種治療方式且已經接受或不適宜接受骨髓移植的進展性多發性骨髓瘤病人。"
    ],
    "does": "2270",
    "packageUnit": [
        {
            "packageSpec": "10、30毫升",
            "packageUnit": "13"
        },
        {
            "packageSpec": "100小瓶以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "B",
    "mainCategory": "B",
    "drBaseId": "B3EA52F3-F33A-4ED9-AF24-61AAEEE6F695",
    "subCategory": [
        "B02"
    ],
    "ingredientsDesc": [
        "DOXORUBICIN HCL"
    ],
    "restraintItemsCode": [
        "02",
        "24"
    ],
    "applicantName": "台灣瑞迪博士有限公司",
    "applicantAddr": "臺北市信義區信義路5段7號57樓之1(5727室)",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "E1E6578A-2553-4122-B44F-18BD46DDC673",
            "factoryCode": "1",
            "factoryName": "NATCO PHARMA LIMITED",
            "factoryAddr": "PHARMA DIVISION KOTHUR, RANGAREDDY DISTRICT, TELANGANA, INDIA",
            "factoryCompanyAddr": "",
            "countryCode": "IN",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIN1010100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1003000610",
            "ingredientsName": "DOXORUBICIN HCL",
            "ingredientsDesc": "DOXORUBICIN HCL",
            "concentDesc": "",
            "concent": "2.0000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [
        {
            "applicantName": "中化裕民健康事業股份有限公司",
            "certNo": "DHA05202788611",
            "approveDocNo": "1120704482",
            "authDate": "2023-03-14",
            "validDate": "2025-03-14"
        }
    ],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01DB01"
        }
    ],
    "licBaseId": "58F5FB3A-60B1-41B1-AC2E-DFC35FA369CE"
}